|
|
Article: Agilex BioSciences Presents GlucoScreen at 'Investment in Innovation' in Boston.
- Article from:
- PR Newswire
- Article date:
- October 30, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif. -- Agilex BioSciences, Inc. presented at "Investment in Innovation: A Preview of Early-Stage Medical Technology Companies" at the Boston Sheraton on October 24. Over 300 industry professionals were on hand to hear about Agilex, its patented technologies and unique marketing strategies.
Agilex highlighted the world's first saliva-based screening test to measure elevated blood glucose levels for diabetes risk. Patent-pending GlucoScreen(TM) currently requires a simple collection procedure and sample mailing to its CLIA-certified laboratory. Agilex is working with a highly respected University and has licensed its patented measurement technologies ...
Related newspaper, magazine, and journal articles:
|
|
Article: TM TECHNOLOGIES CORP. ISSUES STATEMENT
PR Newswire;
March 20, 1995 ;
700+ words
...TORONTO, March 20 /PRNewswire/ -- Tm Technologies Corp. (VSE: TMC) made the ... behalf of its wholly-owned subsidiary, Tm Technologies, Inc. of Woburn, Massachusetts ... trial, in the action commenced against Tm Technologies, Inc. ("Tm") by ID Biomedical ...
|
|